ResearchSafe

Apollo Stack vs Immortality Stack

A side-by-side research comparison of Apollo Stack and Immortality Stack across mechanism, dosing, half-life, benefits, side effects and research status.

Comparison table

AttributeApollo StackImmortality Stack
Full nameApollo (Semaglutide + 5-Amino-1MQ + MOTS-c + Tesamorelin)Immortality (Epithalon + NAD+ + SS-31 + FOXO4-DRI)
CategoryPopular StacksPopular Stacks
StatusResearch stackResearch stack
MechanismSemaglutide activates GLP-1 receptors for appetite/glucose control. 5-Amino-1MQ inhibits NNMT to boost NAD+ and cellular energy. MOTS-c activates AMPK like exercise. Tesamorelin specifically targets visceral fat through GH-mediated lipolysis.Epithalon activates telomerase to maintain telomere length. NAD+ restores age-declined sirtuins and PARP activity. SS-31 (Elamipretide) stabilizes mitochondrial cardiolipin preventing ROS damage. FOXO4-DRI disrupts FOXO4-p53 interaction, selectively triggering apoptosis in senescent cells.
Molecular weightMultiple compoundsMultiple compounds
Half-lifeSemaglutide: ~7 days, 5A1MQ: ~6h, MOTS-c: ~4h, Tesamorelin: ~30minEpithalon: ~3-4h, NAD+: ~2-4h, SS-31: ~4-6h, FOXO4-DRI: ~12-24h
BioavailabilityVariable by componentVariable; primarily injectable
Typical doseSema 0.25-2.4mg/wk + 5A1MQ 100mg 2x/day + MOTS-c 10mg 3x/wk + Tesa 2mg/dayEpithalon 10mg/day + NAD+ 250mg + SS-31 40mg/day + FOXO4-DRI 10mg/kg cycles
FrequencyVariable by componentEpithalon: 10-day courses. Others: daily/cycled
RouteSC injection + OralSubcutaneous injection + IV (NAD+)

Apollo Stack reported benefits

  • Dramatic fat loss
  • Visceral fat reduction
  • Metabolic rate increase
  • Appetite control
  • Improved insulin sensitivity
  • Cellular energy boost

Immortality Stack reported benefits

  • Telomere length maintenance
  • Senescent cell clearance
  • Mitochondrial rejuvenation
  • Cellular energy restoration
  • Reduced biological age markers
  • DNA repair support

Related comparisons

Research and educational reference only. Not medical advice.